Beta-receptor subtypes in the canine coronary circulation.

Area of Science:

• Cardiovascular Pharmacology
• Adrenergic Receptor Research

Background:

• Determining coronary vascular beta-receptor subtypes in vivo is challenging due to local metabolic vasodilation.
• A non-beating cardiac model is necessary to isolate beta-receptor effects from cardiac activity.

Purpose of the Study:

• To investigate the roles of beta 1 and beta 2 adrenergic receptors in coronary vasodilation.
• To differentiate receptor subtypes in coronary resistance vessels independent of cardiac chronotropic and inotropic effects.

Main Methods:

• Utilized a closed-chest, anesthetized dog model with induced atrioventricular block and cardiac pacing to create prolonged asystoles.
• Administered isoproterenol (a combined beta 1/beta 2 agonist) via intracoronary injection, perfusing the coronary circulation at constant pressure.
• Assessed coronary blood flow changes and used selective beta 1 (practolol, L 650,744) and beta 2 (ICI 118,551) antagonists to block receptor activity.

Main Results:

• Isoproterenol significantly increased coronary blood flow during asystole.
• Both beta 1-selective and beta 2-selective antagonists effectively blocked isoproterenol-induced coronary vasodilation.
• In contrast, femoral vasodilation by isoproterenol was blocked only by beta 2-selective antagonists.

Conclusions:

• Both beta 1 and beta 2 adrenergic receptors are present and functional in coronary resistance vessels.
• Isoproterenol stimulates both beta 1 and beta 2 receptors in the coronary vasculature, leading to vasodilation.
• This study successfully characterized coronary beta-receptor subtypes by eliminating confounding cardiac effects.